Abstract Details
|
Larry B. Goldstein, MD, FAHA, FAAN
(University of Kentucky)
PRESENTER |
The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care. |
| Meheroz H. Rabadi, MD, FAAN (Dept of VA Medical Center #127) | Dr. Rabadi has nothing to disclose. |
| Michael A. Vogelbaum, MD, PhD, FACS (Cleveland Clinic Lerner College of Med) | No disclosure on file |
| Michael J. Reding, MD | No disclosure on file |
| Laura Lennihan, MD, FAAN (Neurological Institute of New York) | No disclosure on file |
| David C. Good, MD, FAAN | Dr. Good has a non-compensated relationship as a President with World Federation for Neurorehabilitation that is relevant to AAN interests or activities. |
| Alexander W. Dromerick, MD (National Rehabilitation Hospital) | No disclosure on file |
| No disclosure on file | |
| Gregory Samsa | No disclosure on file |